Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade glioma

Joshua D. Bernstock(National Institutes of Health), Gregory K. Friedman(The University of Texas MD Anderson Cancer Center), E. Antonio Chiocca(Brigham and Women's Hospital), Jakob V. E. Gerstl(Boston University), Sarah E. Blitz(Brigham and Women's Hospital), Samantha E. Hoffman(Harvard University)
Neuro-Oncology Advances
January 1, 2023
10.1093/noajnl/vdad081
Cited by 13

Related Papers

Global, Regional, and National Economic Consequences of Stroke
|Stroke|2023|137
SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke
|EBioMedicine|2019|56
Leveraging artificial intelligence in ischemic stroke imaging
|Journal of Neuroradiology|2021|51
Incidence and clinical outcomes of perforations during mechanical thrombectomy for medium vessel occlusion in acute ischemic stroke: A retrospective, multicenter, and multinational study
|European Stroke Journal|2024|49
Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
|Scientific Reports|2017|41